MarketCap
Innate Pharma S.A. IPHA
€ 1.32
-6.96%
Facebook
X
Telegram
Land |
 Frankreich |
IPO-Jahr |
2019 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
89.6 M |
Marktkapitalisierung |
$ 132 M |
EBITDA (LTM) |
$ -157 M |
P/E (LTM) |
-0.88 |
P/S (LTM) |
5.08 |
EPS (LTM) |
-1.72 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Ionis Pharmaceuticals
IONS
|
$ 43.42 | 1.13 % | $ 6.95 B | Nasdaq Global Select Market,SPB |  USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.49 | 0.87 % | $ 565 M | Nasdaq Global Select Market | USA |
 |
Inventiva S.A.
IVA
|
$ 3.67 | -1.08 % | $ 219 M | Nasdaq Global Market | France |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 205.67 | -3.89 % | $ 12.5 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 266.51 | 1.02 % | $ 642 B | NYSE,SPB | USA |
 |
Kamada Ltd.
KMDA
|
$ 7.93 | 2.06 % | $ 457 M | Nasdaq Global Select Market |  Israel |
 |
Krystal Biotech
KRYS
|
$ 313.53 | 0.65 % | $ 9.07 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 9.64 | 0.31 % | $ 845 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 114.86 | 3.7 % | $ 9.7 B | Nasdaq Global Market | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.0 | -0.1 % | $ 230 M | NYSE American | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 31.65 | 7.8 % | $ 1.51 T | Nasdaq Global Select Market | France |
 |
Longeveron
LGVN
|
$ 1.61 | 0.62 % | $ 28.3 B | Nasdaq Global Select Market | USA |
 |
Eli Lilly and Company
LLY
|
$ 1 277.31 | 0.3 % | $ 1.15 T | NYSE,SPB | USA |
 |
Lipocine
LPCN
|
$ 1.43 | -0.69 % | $ 7.79 M | Nasdaq Global Select Market | USA |
 |
Larimar Therapeutics
LRMR
|
$ 2.22 | -5.53 % | $ 184 M | Nasdaq Global Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 25.97 | 1.64 % | $ 103 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 6.9 | 6.12 % | $ 8.17 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.17 | -3.56 % | $ 137 M | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.64 | -0.88 % | $ 68 M | Nasdaq Global Select Market |  Canada |
 |
Merck & Co.
MRK
|
$ 140.44 | -3.32 % | $ 351 B | NYSE,SPB | USA |
 |
Moderna
MRNA
|
$ 197.65 | -1.23 % | $ 76.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Adial Pharmaceuticals
ADIL
|
$ 3.73 | -4.97 % | $ 2.49 M | Nasdaq Capital Market | USA |
 |
Revolution Medicines
RVMD
|
$ 183.82 | -1.7 % | $ 34.9 B | Nasdaq Global Select Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 7.99 | -2.86 % | $ 538 B | Nasdaq Capital Market |  Britain |
 |
Alector
ALEC
|
$ 1.83 | -0.27 % | $ 188 M | Nasdaq Global Select Market,SPB | USA |
 |
Aligos Therapeutics
ALGS
|
$ 4.55 | -4.81 % | $ 45 M | Nasdaq Global Select Market | USA |
 |
Alkermes plc
ALKS
|
$ 44.42 | 1.8 % | $ 7.32 B | Nasdaq Global Select Market | Irlanda |
 |
Allogene Therapeutics
ALLO
|
$ 1.22 | -2.8 % | $ 269 M | Nasdaq Global Select Market,SPB | USA |
 |
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | USA |
 |
Amgen
AMGN
|
$ 444.7 | 1.24 % | $ 239 B | Nasdaq Global Select Market,SPB | USA |
 |
Amarin Corporation plc
AMRN
|
$ 12.13 | 2.88 % | $ 5.03 B | Nasdaq Global Market | Irlanda |
 |
Amneal Pharmaceuticals
AMRX
|
$ 21.07 | 3.39 % | $ 6.6 B | NYSE | USA |
 |
AnaptysBio
ANAB
|
$ 48.78 | 0.1 % | $ 1.41 B | Nasdaq Global Select Market,SPB | USA |
 |
Aclaris Therapeutics
ACRS
|
$ 3.77 | 0.4 % | $ 462 M | Nasdaq Global Select Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.3 | -4.96 % | $ 232 M | Nasdaq Global Market |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Adagene
ADAG
|
$ 2.49 | 3.32 % | $ 147 M | Nasdaq Global Market |  China |
 |
ADMA Biologics
ADMA
|
$ 11.05 | 3.46 % | $ 2.63 B | Nasdaq Global Market | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
$ 26.3 | 3.1 % | $ 3.99 B | Nasdaq Global Select Market,SPB | USA |
 |
Agenus
AGEN
|
$ 6.19 | -2.21 % | $ 184 M | Nasdaq Capital Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 36.67 | -0.91 % | $ 2.13 B | Nasdaq Global Select Market,SPB | USA |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.2 | 0.12 % | $ 805 M | Nasdaq Global Select Market | Canada |
 |
ADC Therapeutics SA
ADCT
|
$ 1.51 | 4.51 % | $ 192 M | NYSE | Schweiz |
 |
AbbVie
ABBV
|
$ 286.99 | 0.47 % | $ 508 B | NYSE,SPB | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
$ 19.75 | 0.08 % | $ 3.33 B | Nasdaq Global Select Market,SPB | USA |
 |
Artelo Biosciences
ARTL
|
$ 2.32 | -10.98 % | $ 439 K | Nasdaq Global Select Market | USA |
 |
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market |  Germany |
 |
Aquestive Therapeutics
AQST
|
$ 3.98 | -0.63 % | $ 426 M | Nasdaq Global Market | USA |
 |
Armata Pharmaceuticals
ARMP
|
$ 3.46 | -4.95 % | $ 125 M | NYSE American | USA |